Elrexfio 44 mg/1.1mL
elranatamab-bcmm · INJECTION, SOLUTION · U.S. Pharmaceuticals
No Recall History
Plain English
Elrexfio is a injection, solution containing elranatamab-bcmm at 44 mg/1.1mL, taken subcutaneous. Manufactured by U.S. Pharmaceuticals.
Key Facts
- Brand Name
- Elrexfio
- Generic Name
- elranatamab-bcmm
- NDC Code (Product)
63539-252- Manufacturer
- U.S. Pharmaceuticals
- Strength
- 44 mg/1.1mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761345
- Marketing Start
- 08/15/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Elrexfio used for?
Elrexfio contains elranatamab-bcmm. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Elrexfio a controlled substance?
Elrexfio is not classified as a controlled substance by the DEA.
What is the generic name for Elrexfio?
The generic name for Elrexfio is elranatamab-bcmm. There are no other listed brand versions of elranatamab-bcmm.
What is the NDC code for Elrexfio 44 mg/1.1mL?
The NDC (National Drug Code) for Elrexfio 44 mg/1.1mL is 63539-252, listed by U.S. Pharmaceuticals.
Other Elrexfio Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)